Recruiting × Head and Neck Neoplasms × Genitourinary × Clear all A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 Recruiting
310 enrolled
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/2 Recruiting
300 enrolled
MOMENTUM
Recruiting
8,000 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
DP-04
Recruiting
100 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
216 enrolled
Improving Care for Rural Patients With Solid Tumors
Phase NA Recruiting
320 enrolled
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 Recruiting
740 enrolled
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
51 enrolled
TAGNOT
Phase 1/2 Recruiting
58 enrolled
CAMPERR
Recruiting
7,000 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Phase 1 Recruiting
120 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Recruiting
270 enrolled
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Phase 1/2 Recruiting
126 enrolled
OvAR-Y
Recruiting
10 enrolled
FASCINATE
Phase NA Recruiting
100 enrolled
JUMP
Phase NA Recruiting
86 enrolled
START-001
Phase 1/2 Recruiting
365 enrolled
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
115 enrolled
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2 Recruiting
150 enrolled
MOIO
Phase 3 Recruiting
646 enrolled
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 Recruiting
11 enrolled
A Multicenter Cancer Biospecimen Collection Study
Recruiting
1,650 enrolled
EVIDENT
Recruiting
600 enrolled
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
Phase NA Recruiting
150 enrolled
MOHCCN-O
Recruiting
500 enrolled
ReRT
Phase NA Recruiting
1,800 enrolled
COACH
Phase NA Recruiting
625 enrolled
SkinHealth
Recruiting
420 enrolled
OligoRARE
Phase NA Recruiting
200 enrolled
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Phase 1 Recruiting
18 enrolled
LEARN
Recruiting
300 enrolled
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Recruiting
990 enrolled
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Phase 1/2 Recruiting
125 enrolled
POSITive
Recruiting
265 enrolled
Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers
Recruiting
320 enrolled
ART-02
Recruiting
649 enrolled
ONCOPRO
Phase NA Recruiting
410 enrolled